Interactions of the antitumor drug, etoposide, with reduced thiols in vitro and in vivo
- 31 December 1987
- journal article
- Published by Elsevier BV in Chemico-Biological Interactions
- Vol. 62 (3), 237-247
- https://doi.org/10.1016/0009-2797(87)90025-1
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- In vitro metabolism of etoposide (VP-16-213) by liver microsomes and irreversible binding of reactive intermediates to microsomal proteinsBiochemical Pharmacology, 1987
- Peroxidative free radical formation and O-demethylation of etoposide(VP-16) and teniposide(VM-26)Biochemical and Biophysical Research Communications, 1986
- Inhibition of epipodophyllotoxin cytotoxicity by interference with topoisomerase-mediated DNA cleavageBiochemical Pharmacology, 1985
- Microsomal interactions and inhibition of lipid peroxidation by etoposide (VP-16, 213): Implications for mode of actionBiochemical Pharmacology, 1985
- Etoposide (VP-16–213)New England Journal of Medicine, 1985
- Irreversible binding of etoposide (VP-16-213) to deoxyribonucleic acid and proteinsBiochemical Pharmacology, 1984
- Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16-213 and VM26: a quantitative structure-activity relationshipBiochemistry, 1984
- Free radical metabolism of VP-16 and inhibition of anthracycline-induced lipid peroxidationBiochemical Pharmacology, 1983
- VM 26 and VP 16–213: A comparative analysisCancer, 1977
- Effect of VP-16-213 on the intracellular degradation of DNA in HeLa cellsBiochemistry, 1976